Drop in well-being of ARMD patients under treatment with anti-VEGF injections during the COVID-19 pandemic

PURPOSE: Patients with age-related macular degeneration (ARMD) are required to follow a treatment protocol that requires regular follow-ups. The COVID-19 pandemic has created an additional burden for patients with ARMD under treatment with anti-vascular endothelial growth factor (anti-VEGF) injectio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mylona, Ioanna, Papadopoulou, Kalliopi, Roumelis, Serafeim, Floros, Georgios D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972774/
https://www.ncbi.nlm.nih.gov/pubmed/35362811
http://dx.doi.org/10.1007/s10792-022-02296-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972774/
https://www.ncbi.nlm.nih.gov/pubmed/35362811
http://dx.doi.org/10.1007/s10792-022-02296-4

Ejemplares similares